Deutsche Bank Ag\ Protara Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$8.68 - $16.99 $21,526 - $42,135	-2,480 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$13.75 - $23.86 $3,217 - $5,583	-234 Reduced 8.62%	2,480 $0
Q4 2020 Feb 16, 2021	BUY	$16.97 - $25.34 $28,645 - $42,773	1,688 Added 164.52%	2,714 $66,000
Q3 2020 Nov 12, 2020	BUY	$16.76 - $31.89 $1,642 - $3,125	98 Added 10.56%	1,026 $17,000
Q2 2020 Aug 13, 2020	BUY	$22.0 - $60.7 $20,416 - $56,329	928 New	928 $27,000

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $65.5M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.